1 – 31 of 31
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
2024) In Scandinavian Journal of Surgery(
- Contribution to journal › Article
- 2023
-
Mark
Model-based screening for pancreatic cancer in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Surgical resection of pancreatic cancer with synchronous hepatic oligometastases : Real benefit or selection bias?
(
- Contribution to journal › Letter
- 2021
-
Mark
Projected economic burden of pancreatic cancer in Sweden in 2030
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
- 2019
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Proteomic and genomic profiling of pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review
-
Mark
Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications
(
- Contribution to journal › Scientific review
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
- 2017
-
Mark
Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer : a two-center retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
Immune checkpoint therapy for pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Yesterday, today and tomorrow
(
- Contribution to journal › Article
-
Mark
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
(
- Contribution to journal › Article
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Pancreatic Cancer - Early Detection, Prognostic Factors, and Treatment
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Neoadjuvant/Downstaging Radiochemotherapy in Marginally Resectable Pancreatic Cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Personalizing pancreatic cancer medicine: what are the challenges?
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
(
- Contribution to journal › Article